tiprankstipranks
Trending News
More News >

Nanobiotix price target lowered to $8 from $12 at Guggenheim

Guggenheim lowered the firm’s price target on Nanobiotix (NBTX) to $8 from $12 and keeps a Buy rating on the shares. After the company reported FY24 earnings consistent with prior disclosures, the firm is updating its model to reflect second half results and remove assumptions for recurrent/metastatic head and neck squamous cell carcinoma.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue